HistoSonics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2009-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.histosonics.com
Clinical Trials
10
Active:3
Completed:2
Trial Phases
1 Phases
Not Applicable:9
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Not Applicable
9 (100.0%)The Edison System for Treatment of Benign Prostatic Hyperplasia (BPH) Using Histotripsy
Not Applicable
Not yet recruiting
- Conditions
- Benign Prostatic Hyperplasia
- First Posted Date
- 2025-10-09
- Last Posted Date
- 2025-10-09
- Lead Sponsor
- HistoSonics, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT07214675
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Recruiting
- Conditions
- Liver NeoplasmsBenign Liver TumorTumor LiverPrimary Liver CancerSecondary Liver Cancer
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2025-10-01
- Lead Sponsor
- HistoSonics, Inc.
- Target Recruit Count
- 5000
- Registration Number
- NCT06486454
- Locations
- 🇺🇸
University of Wisconsin, Madison, Wisconsin, United States
🇺🇸Mission Hospital, Mission Viejo, California, United States
🇺🇸AdventHealth Altamonte Springs, Altamonte Springs, Florida, United States
The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy
Not Applicable
Recruiting
- Conditions
- Pancreatic CancerTumor of PancreasAdenocarcinoma of the PancreasPancreas Cancer
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- HistoSonics, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT06282809
- Locations
- 🇪🇸
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)
Not Applicable
Active, not recruiting
- Conditions
- Renal CancerTumor, SolidTumor, BenignTumorKidney Cancer
- First Posted Date
- 2023-04-19
- Last Posted Date
- 2025-10-09
- Lead Sponsor
- HistoSonics, Inc.
- Target Recruit Count
- 67
- Registration Number
- NCT05820087
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸University of California, Los Angeles (UCLA), Los Angeles, California, United States
🇺🇸Providence Mission Hosptial, Mission Viejo, California, United States
The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy
Not Applicable
Completed
- Conditions
- Tumor, BenignTumor, SolidKidney NeoplasmsRenal CancerKidney CancerTumor
- First Posted Date
- 2022-06-27
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- HistoSonics, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT05432232
- Locations
- 🇬🇧
Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
- Prev
- 1
- 2
- Next
News
No news found